Ellen M.
- Country
- Belgium
- Department
- Nephrology
Research Overview
- Evaluation of Baxdrostat and Dapagliflozin on Chronic Kidney Disease Progression in Hypertensive Patients: A Randomized, Double-Blind, Active-Controlled Phase III Trial
- Evaluation of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients with Severe Chronic Kidney Disease: A Randomized Controlled Trial
- Efficacy and Safety of Baxdrostat and Dapagliflozin on Renal and Cardiovascular Outcomes in Chronic Kidney Disease with Hypertension
Data & Insights
Has run more than one trial at 113 of 327 partner sites.
Specializations
Nephrology Focus
This investigator specializes in the treatment of chronic kidney disease (CKD), with particular emphasis on exploring innovative therapeutic approaches for patients with concurrent hypertension.
- Renal Function Management
- Blood Pressure Control in CKD
- Glomerular Filtration Assessment
Their research centers on evaluating treatment combinations to enhance renal outcomes in complex cases.
Cardiovascular Health
The investigator focuses on addressing cardiovascular complications in kidney disease patients, studying interventions that target both blood pressure management and cardiovascular risk reduction.
- Cardiovascular Risk Management
- Therapeutic Combination Strategies
- Long-term Clinical Outcomes
Their work examines the intersection of renal and cardiovascular health in complex patient populations.
Clinical Innovation
The investigator explores novel therapeutic combinations for treating complex renal conditions, focusing on interventions that may slow disease progression and improve patient outcomes.
- Treatment Optimization
- Disease Progression Analysis
- Patient Safety Assessment
Their research aims to advance treatment options for patients with concurrent kidney and cardiovascular conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.